Syndax Pharmaceuticals, Inc.

Syndax Pharmaceuticals, Inc. (SNDX) — Form 4: Insider transaction

4SNDXFiled Nov 12, 2026, 11:05 AM ET· Period Nov 9, 2026

About this filing

Syndax Pharmaceuticals, Inc. (SNDX) filed Form 4 (insider transaction) with the SEC on Nov 12, 2026. Form 4 reports a company insider’s trades in the company’s shares.

View original filing on SEC.gov

Key facts

Key facts aren’t available for this filing right now. The original on SEC.gov has the full filing.

More SNDX filings

3
Initial insider holdings
Filed Nov 12, 2026
10-Q
Quarterly report
Filed Nov 2, 2026
8-K
Current report
Filed Nov 2, 2026
4
Insider transaction
Filed Oct 30, 2026
144
Proposed sale of shares
Filed Oct 29, 2026
SC 13G
Ownership over 5% (passive)
Filed Aug 7, 2026

Not investment advice. Summaries can contain errors; the SEC filing is the official record.